NCT05141396 Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
| NCT ID | NCT05141396 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intermountain Health Care, Inc. |
| Condition | Respiration, Artificial |
| Study Type | INTERVENTIONAL |
| Enrollment | 13,400 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 13,400 participants in total. It began in 2022-09-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this trial is to evaluate if augmenting a usual audit and feedback implementation approach with telehealth-enabled support improves coordinated spontaneous awakening/breathing trials and patient outcomes for mechanically ventilated patients.
Eligibility Criteria
Inclusion criteria: * Patient age \>=16 years admitted to study hospital ICU * Intubated and mechanically ventilated Exclusion criteria: * Patient with pre-existing brain death admitted to study hospital for organ donation * Died within 24 hours of intubation
Contact & Investigator
Colin Grissom, MD
PRINCIPAL INVESTIGATOR
Intermountain Health Care, Inc.
Frequently Asked Questions
Who can join the NCT05141396 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Respiration, Artificial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05141396 currently recruiting?
Yes, NCT05141396 is actively recruiting participants. Contact the research team at carlos.barbagelata@imail.org for enrollment information.
Where is the NCT05141396 trial being conducted?
This trial is being conducted at American Fork, United States, Cedar City, United States, Layton, United States, Logan, United States and 7 additional locations.
Who is sponsoring the NCT05141396 clinical trial?
NCT05141396 is sponsored by Intermountain Health Care, Inc.. The principal investigator is Colin Grissom, MD at Intermountain Health Care, Inc.. The trial plans to enroll 13,400 participants.